Red Cell forms Zephyr AI

By The Science Advisory Board staff writers

Red Cell has formed Zephyr AI to transform drug discovery and precision medicine through the integration of artificial intelligence (AI).

Zephyr integrates AI with extensive datasets discover new therapies, applications for existing therapeutics, and advanced biomarkers for individualized treatments.

The company is co-founded by Yisroel Brumer, PhD, formerly of the Office of the Secretary of Defense; Grant Verstandig, former CEO of Rally Health; and Jeff Sherman, former machine learning architect at Rally Health.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?